ArticleJournal of the National Cancer Institute2015

Carboxylesterase 2 as a Determinant of Response to Irinotecan and Neoadjuvant FOLFIRINOX Therapy in Pancreatic Ductal Adenocarcinoma.

Michela Capello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.